Variant report
Variant | esv15410 |
---|---|
Chromosome Location | chr7:12122220-12122980 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1990600 | chr7:12122223-12122224 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs7784346 | chr7:12122251-12122252 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs562861342 | chr7:12122267-12122268 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs4721026 | chr7:12122356-12122357 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs185547012 | chr7:12122358-12122359 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs199650833 | chr7:12122360-12122361 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs530062494 | chr7:12122383-12122384 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs73676329 | chr7:12122385-12122386 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs13241222 | chr7:12122400-12122401 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs189569898 | chr7:12122445-12122446 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs552217110 | chr7:12122454-12122455 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs10275399 | chr7:12122470-12122471 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs537803096 | chr7:12122480-12122481 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs137970578 | chr7:12122483-12122484 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs182305825 | chr7:12122503-12122504 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs10275524 | chr7:12122555-12122556 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs553922614 | chr7:12122558-12122559 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs576992760 | chr7:12122621-12122622 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs559652650 | chr7:12122639-12122640 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs7788708 | chr7:12122657-12122658 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs151115818 | chr7:12122658-12122659 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs573799037 | chr7:12122675-12122676 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs576462008 | chr7:12122685-12122686 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs542203139 | chr7:12122687-12122688 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs7788863 | chr7:12122749-12122750 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs79948859 | chr7:12122797-12122798 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
27 | rs17589439 | chr7:12122826-12122827 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs560469749 | chr7:12122870-12122871 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs144422295 | chr7:12122877-12122878 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs532307153 | chr7:12122890-12122891 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs7789227 | chr7:12122891-12122892 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs531349534 | chr7:12122935-12122936 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs141059600 | chr7:12122938-12122939 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs567743396 | chr7:12122946-12122947 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs7808117 | chr7:12122957-12122958 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs7808118 | chr7:12122960-12122961 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs111791002 | chr7:12122967-12122968 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs192494723 | chr7:12122973-12122974 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Biliary cancer | 19435499 | CNVD |
Cancer | 16751803 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Wilms tumour | 21544195 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Glioma | 21971842 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
colon cancer | 17210682 | CNVD |
Lung adenocarcinoma | 21810691 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Hypothalamic hamartomas | 18252217 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Leukemia | 23979775 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Autism | 22495311 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Melanoma | 17363583 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16272173 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Medulloblastoma | 17653508 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 19242612 | CNVD |
Autism | 18414403 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Autism | 22495309 | CNVD |
Cancer | 21637783 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16397240 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Multiple myeloma | 17550852 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:12115600-12130400 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
2 | chr7:12119400-12122600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
3 | chr7:12120200-12122400 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
4 | chr7:12120200-12122800 | Weak transcription | H1 Cell Line | embryonic stem cell |
5 | chr7:12120200-12122800 | Weak transcription | H9 Cell Line | embryonic stem cell |
6 | chr7:12120400-12122400 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
7 | chr7:12122000-12122800 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
8 | chr7:12122200-12122600 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
9 | chr7:12122200-12123400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
10 | chr7:12122400-12123200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
11 | chr7:12122400-12123200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
12 | chr7:12122600-12123200 | Flanking Active TSS | HUES48 Cell Line | embryonic stem cell |
13 | chr7:12122600-12123200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
14 | chr7:12122800-12123000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
15 | chr7:12122800-12123200 | Enhancers | H1 Cell Line | embryonic stem cell |
16 | chr7:12122800-12123400 | Enhancers | H9 Cell Line | embryonic stem cell |